Divio Technologies (DIVIO) Q2 2025 earnings summary

Executive summary

• Net sales grew 62% year-over-year in Q2 2025, reaching KSEK 8,231, with MRR up 34% to KUSD 207, driven by a major Swiss healthcare client and agency partnerships.

• EBITDA improved to KSEK -192 from -2,567 in Q2 2024; year-to-date EBITDA turned positive at KSEK 150.

• Strategic partnerships expanded, including a new agreement with Zühlke and an expanded framework with the Swiss Armed Forces.

• A capital raise of MSEK 9.6 was completed post-quarter to address liquidity needs and support growth.

Financial highlights

• Q2 2025 net sales: KSEK 8,231 (up 62% YoY); subscription revenue: KSEK 6,343 (up 31% YoY); professional services: KSEK 1,888 (up 758% YoY).

• Year-to-date net sales: KSEK 16,684 (up 64% YoY); EBITDA: KSEK 150 (from -6,871); EBIT: KSEK -2,967 (from -9,980).

• Net financial items improved to KSEK 2,948 in Q2, mainly due to unrealized FX effects.

• Cash position at quarter-end: KSEK 1,712, down from KSEK 5,326 YoY.

• EPS before dilution: SEK 0.00 in Q2 (from -0.03 YoY); year-to-date: SEK -0.01 (from -0.07 YoY).

Outlook and guidance

• Management expects to reach positive cash flow soon, with several promising deals in late-stage negotiations.

• Focus remains on converting free users to paying customers and leveraging agency partnerships for growth.

• Additional investments planned if warrants from the recent capital raise are exercised.